DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
DRIVIN G ROWTH - Dr. Reddy's
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
230<br />
report of the directors<br />
The Directors present their report together with the audited financial statements of the Company for the financial year ended<br />
December 31, 2001.<br />
1. DIRECTORS<br />
The Directors of the Company in office at the date of this report are:<br />
KALLAM ANJI REDDY (CHAIRMAN)<br />
KALLAM SATISH REDDY<br />
GUNUPATI VENKATESWARA PRASAD<br />
VIKRAM BERY<br />
2. PRINCIPAL ACTIVITIES<br />
The principal activities of the Company are to act as importers, exporters, wholesalers, retailers, manufacturers, manufacturers’<br />
agents and representatives, marketing agents, commission agents, distributors of medicinal and pharmaceutical products, health<br />
care, beauty care, toiletries and related items and provision of services to related corporations.<br />
There have been no significant changes in the nature of these activities during the financial year.<br />
3. ACQUISITION OR DISPOSAL OF SUBSIDIARIES<br />
There were no acquisitions or disposals of subsidiaries during the financial year.<br />
4. RESULTS FOR THE FINANCIAL YEAR S$<br />
Loss for the year after taxation (97,962)<br />
Accumulated losses brought forward (682,734)<br />
Accumulated losses carried forward (780,696)<br />
5. TRANSFERS TO OR (FROM) RESERVES OR PROVISIONS<br />
During the financial year, there were no material transfers to or from reserves or provisions other than those disclosed in the<br />
attached financial statements.<br />
6. SHARES OR DEBENTURES ISSUES<br />
No shares or debentures were issued during the financial year.<br />
7. ARRANGEMENTS TO ENABLE DIRECTORS TO ACQUIRE SHARES OR DEBENTURES<br />
Neither at the end of the financial year nor at any time during the financial year did there subsist any arrangement whose object<br />
was to enable the Directors of the Company to acquire benefits by means of the acquisition of shares or debentures in the<br />
Company or any other body corporate.<br />
8. DIRECTORS’ INTERESTS IN SHARES AND DEBENTURES<br />
The Directors holding office at the end of the financial year and their interest in the share capital of the Company or its related<br />
corporations as recorded in the register of directors’ shareholdings kept by the Company under section 164 of the Singapore<br />
Companies Act, Cap. 50 were as follows:<br />
Name of Directors<br />
KALLAM ANJI REDDY<br />
At beginning of year At end of year<br />
Direct holding 193,396 193,396<br />
Deemed interest 159,360 159,360<br />
KALLAM SATISH REDDY<br />
Direct holding 138,150 138,150<br />
GUNUPATI VENKATESWARA PRASAD<br />
Direct holding 600 600<br />
Deemed interest 600 600<br />
The above represent their respective interest in <strong>Dr</strong>. Reddy’s Laboratories Ltd, being the ultimate holding Company.<br />
REDDY PHARMACEUTICALS SINGAPORE PTE LTD. | FINANCIALS | ANNUAL REPORT 2001
Change language